% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Feldheim:282355,
      author       = {J. Feldheim and T. Schmidt$^*$ and C. Oster$^*$ and J.
                      Feldheim and M. Stuschke and W. Stummer and O. Grauer and B.
                      Scheffler$^*$ and C. Hagemann and U. Sure and C.
                      Kleinschnitz$^*$ and L. Lazaridis$^*$ and S. Kebir$^*$ and
                      M. Glas$^*$},
      title        = {{T}elemedicine in {N}euro-{O}ncology-{A}n {E}valuation of
                      {R}emote {C}onsultations during the {COVID}-19 {P}andemic.},
      journal      = {Cancers},
      volume       = {15},
      number       = {16},
      issn         = {2072-6694},
      address      = {Basel},
      publisher    = {MDPI},
      reportid     = {DKFZ-2023-01739},
      pages        = {4054},
      year         = {2023},
      abstract     = {In order to minimize the risk of infections during the
                      COVID-19 pandemic, remote video consultations (VC)
                      experienced an upswing in most medical fields. However,
                      telemedicine in neuro-oncology comprises unique challenges
                      and opportunities. So far, evidence-based insights to
                      evaluate and potentially customize current concepts are
                      scarce. To fill this gap, we analyzed >3700
                      neuro-oncological consultations, of which >300 were
                      conducted as VC per patients' preference, in order to detect
                      how both patient collectives distinguished from one another.
                      Additionally, we examined patients' reasons, suitable/less
                      suitable encounters, VC's benefits and disadvantages and
                      future opportunities with an anonymized survey. Patients
                      that participated in VC had a worse clinical condition,
                      higher grade of malignancy, were more often diagnosed with
                      glioblastoma and had a longer travel distance (all p <
                      0.01). VC were considered a fully adequate alternative to
                      face-to-face consultations for almost all encounters that
                      patients chose to participate in $(>70\%)$ except initial
                      consultations. Most participants preferred to alternate
                      between both modalities rather than participate in one alone
                      but preferred VC over telephone consultation. VC made
                      patients feel safer, and participants expressed interest in
                      implementing other telemedicine modalities (e.g., apps) into
                      neuro-oncology. VC are a promising addition to patient care
                      in neuro-oncology. However, patients and encounters should
                      be selected individually.},
      keywords     = {COVID-19 (Other) / SARS-CoV-2 (Other) / brain (Other) /
                      cancer (Other) / consultations (Other) / glioma (Other) /
                      oncology (Other) / video (Other)},
      cin          = {ED01},
      ddc          = {610},
      cid          = {I:(DE-He78)ED01-20160331},
      pnm          = {899 - ohne Topic (POF4-899)},
      pid          = {G:(DE-HGF)POF4-899},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:37627083},
      pmc          = {pmc:PMC10452255},
      doi          = {10.3390/cancers15164054},
      url          = {https://inrepo02.dkfz.de/record/282355},
}